Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:bortezomib (250:1 mol/mol) |
PharmacoGx | tanespimycin:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZER1 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
mRNA | GOLGA2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | TIMP2 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
mRNA | YIPF2 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | SLIT3 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
mRNA | KLC3 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
mRNA | ABHD12 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
mRNA | SERINC3 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | CREBRF | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
mRNA | ANKRD6 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |